{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:12Z","timestamp":1790803272761,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Brickell Biotech, Inc"},{"name":"Brickell Biotech, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jaad.2020.02.016","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T23:42:04Z","timestamp":1581723724000},"page":"1321-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial"],"prefix":"10.1016","volume":"82","author":[{"given":"Brandon","family":"Kirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2020.02.016_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13555-016-0148-z","article-title":"Current and emerging medical therapies for primary hyperhidrosis","volume":"7","author":"Grabell","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"10","key":"10.1016\/j.jaad.2020.02.016_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00403-016-1697-9","article-title":"Hyperhidrosis: an update on prevalence and severity in the United States","volume":"308","author":"Doolittle","year":"2016","journal-title":"Arch Dermatol Res"},{"issue":"1 Spec No.","key":"10.1016\/j.jaad.2020.02.016_bib3","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/j.1524-4725.2006.32334.x","article-title":"An epidemiological study of hyperhidrosis","volume":"33","author":"Lear","year":"2007","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.016_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/09546634.2017.1309347","article-title":"Axillary hyperhidrosis: a focused review","volume":"28","author":"Sammons","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.016_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.det.2014.06.004","article-title":"Impact of hyperhidrosis on quality of life and its assessment","volume":"32","author":"Hamm","year":"2014","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.016_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12955-017-0693-x","article-title":"The impact of hyperhidrosis on patients\u2019 daily life and quality of life: a qualitative investigation","volume":"15","author":"Kamudoni","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.016_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-1838(83)90021-8","article-title":"Autonomic dysfunction in palmar hyperhidrosis","volume":"8","author":"Shih","year":"1983","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.jaad.2020.02.016_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.11.066","article-title":"The etiology, diagnosis and management of hyperhidrosis: a comprehensive review. Part I. Etiology and clinical work-up","author":"Nawrocki","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.016_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2007.07884.x","article-title":"Use of oral glycopyrronium bromide in hyperhidrosis","volume":"157","author":"Bajaj","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.02.016_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0733-8635(05)70062-0","article-title":"Treatment of hyperhidrosis","volume":"16","author":"Stolman","year":"1998","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2020.02.016_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","article-title":"Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials","volume":"80","author":"Glaser","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.02.016_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.11.066","article-title":"The etiology, diagnosis and management of hyperhidrosis: a comprehensive review. Part II. Therapeutic options","author":"Nawrocki","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2020.02.016_bib13","first-page":"729","article-title":"Hyperhidrosis: management options","volume":"97","author":"McConaghy","year":"2018","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.jaad.2020.02.016_bib14","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11095-005-8174-z","article-title":"Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.jaad.2020.02.016_bib15","first-page":"200","article-title":"Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate\u2014syntheses and pharmacological evaluations","volume":"63","author":"Wu","year":"2008","journal-title":"Pharmazie"},{"issue":"7","key":"10.1016\/j.jaad.2020.02.016_bib16","first-page":"707","article-title":"The Hyperhidrosis Disease Severity Measure-Axillary: conceptualization and development of item content","volume":"17","author":"Kirsch","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2020.02.016_bib18","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1111\/ijd.12822","article-title":"Distinguishing hyperhidrosis and normal physiological sweat production: new data and review of hyperhidrosis data for 1980-2013","volume":"54","author":"Thorlacius","year":"2015","journal-title":"Int J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220302243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220302243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:59Z","timestamp":1759272779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220302243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0190962220302243"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}